Dry Eye

The COMET-2 study is the first of three studies in the AR-15512 phase 3 registration program, with topline results expected by the second half of 2023.

Maria Sampalis, OD, continues her dry eye discussion what factors she considers when diagnosing and treating patients.

This far-less-understood option can fill multiple needs for a practice.

Maria Sampalis, OD, continues her dry eye discussion by sharing what factors she considers when diagnosing and treating patients.

Practices must efficiently integrate optometry and ophthalmology, delegating appropriate care to the proper specialist, in order to ensure patients’ total eye care needs are best met.

Maria Sampalis, OD, shares how she approaches starting the dry eye conversation when diagnosing her patients.

Canine patient case study reveals a surprising diagnosis

New book offers guidelines for understanding and eliminating symptoms of eyestrain.

New activator features a single-piece eye cup and translucent design that allows for more efficient and accurate positioning in the eye.

Check out our latest poll!

Michael Brown, OD, MHS-CL, FAAO reflects on how, sometimes, doctors fail to practice what they preach

Check out our latest poll!

The partnership is in support of the company's latest dry eye relief campaign and part of the launch for its leading global artificial tear drop brand.

Fully recovered COVID-19 patients have a higher prevalence for developing dry eye disease, researchers report.

As an all-in-one handheld device, eyecare practitioners can tailor patients’ needs for MGD treatment in both eyes in approximately 8 to 12 minutes.

Check out this week's cartoon!

With advanced, easy-to-fit multifocal lens technologies, patients don’t need to compromise

SECO hosted its 2022 annual meeting March 9-13 at the Ernest N. Morial Convention Center with a LIVE CE virtual meeting available to online attendees.

Clinical trial launch proves transformative for one optometrist’s career

Tools and therapies for dry eye with contact lens wear

Optometrists at the forefront of ocular basal cell and squamous cell carcinomas

Effective this month, the coverage applies to approximately 70% of all United Healthcare commercial lives.

These habits wreak havoc on your vision

Address key factors and causes to ensure a proper diagnosis and treatment plan

Topline proof-of-concept data are expected by the first quarter of 2023.